The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioXcel Therapeutics, Inc(NASDAQ:BTAI) 
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic re...
Website: http://www.bioxceltherapeutics.com
Founded: 2017
Full Time Employees: 40
Sector: Healthcare
Industry: Biotechnology
BioXcel Therapeutics Number of Twitter Followers
BioXcel Therapeutics Days Payable Outstanding ttm (DPO)
BioXcel Therapeutics Days Receivable Outstanding ttm (DSO)
BioXcel Therapeutics Days Inventory Outstanding ttm (DIO)
BioXcel Therapeutics Op Cashflow Per Share ttm
BioXcel Therapeutics Free Cashflow Per Share ttm
BioXcel Therapeutics Cash Per Share ttm
BioXcel Therapeutics P/S ratio ttm
BioXcel Therapeutics (GAAP) P/E ratio ttm
BioXcel Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.